Info
Clinical presentation-of-renal-cell-carcinoma
- Mostly asx & incidental on imaging
- (minority will present w/ flank pain, hematuria, pyrexia, cachexia, fatigue)
- At presentation:
- 65% localized dz,
- 16% locally advanced,
- 16% met
Siblings
- Epidemiology-of-renal-cell-carcinoma
- Histology and molecular biology-of-renal-cell-carcinoma
- Hereditary RCC and germline testing-of-renal-cell-carcinoma
- Clinical presentation-of-renal-cell-carcinoma
- Staging (TNM classification) and prognosis-of-renal-cell-carcinoma
- Treatment principles-of-renal-cell-carcinoma
- Systemic therapy for metastatic clear cell RCC
- Second-line therapies-of-renal-cell-carcinoma
- Combined-modality therapies-of-renal-cell-carcinoma
- Tyrosine kinase inhibitors-of-renal-cell-carcinoma
- Immunotherapies-of-renal-cell-carcinoma
- mTOR inhibitors-of-renal-cell-carcinoma
- Non-clear cell histology-of-renal-cell-carcinoma